Quantum Cyber NV (QUCY)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Oct 02, 16:00
1.31
-0.02
(-1.50%)
After-Hours: 20:00
Quantum Cyber Price : 1.33 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.36 | 1.36 | 1.29 | 1.33 | 453807.0 |
| Oct 01, 2026 | 1.31 | 1.38 | 1.25 | 1.35 | 446753.0 |
| Sep 30, 2026 | 1.32 | 1.35 | 1.31 | 1.31 | 148053.0 |
| Sep 29, 2026 | 1.37 | 1.37 | 1.29 | 1.29 | 232349.0 |
| Sep 28, 2026 | 1.36 | 1.38 | 1.332 | 1.36 | 206783.0 |
| Sep 25, 2026 | 1.35 | 1.38 | 1.31 | 1.37 | 498640.0 |
| Sep 24, 2026 | 1.32 | 1.34 | 1.285 | 1.33 | 257498.0 |
| Sep 23, 2026 | 1.34 | 1.36 | 1.30 | 1.32 | 242520.0 |
| Sep 22, 2026 | 1.30 | 1.35 | 1.29 | 1.32 | 384487.0 |
| Sep 21, 2026 | 1.37 | 1.38 | 1.30 | 1.30 | 338164.0 |
| Sep 18, 2026 | 1.36 | 1.405 | 1.345 | 1.38 | 297775.0 |
| Sep 17, 2026 | 1.32 | 1.38 | 1.31 | 1.36 | 349360.0 |
| Sep 16, 2026 | 1.32 | 1.34 | 1.292 | 1.31 | 323269.0 |
| Sep 15, 2026 | 1.32 | 1.34 | 1.28 | 1.31 | 533957.0 |
| Sep 14, 2026 | 1.31 | 1.35 | 1.31 | 1.32 | 302410.0 |
| Sep 11, 2026 | 1.40 | 1.40 | 1.33 | 1.34 | 371149.0 |
| Sep 10, 2026 | 1.41 | 1.41 | 1.33 | 1.37 | 744809.0 |
| Sep 09, 2026 | 1.40 | 1.45 | 1.39 | 1.39 | 460276.0 |
| Sep 08, 2026 | 1.54 | 1.56 | 1.41 | 1.42 | 1.366M |
| Sep 04, 2026 | 1.53 | 1.63 | 1.51 | 1.59 | 1.181M |
| Sep 03, 2026 | 1.57 | 1.62 | 1.52 | 1.52 | 1.234M |
| Sep 02, 2026 | 1.53 | 1.65 | 1.50 | 1.60 | 1.331M |
| Sep 01, 2026 | 1.54 | 1.60 | 1.460 | 1.48 | 1.559M |
| Aug 31, 2026 | 1.42 | 1.58 | 1.38 | 1.57 | 1.365M |
| Aug 28, 2026 | 1.48 | 1.50 | 1.355 | 1.42 | 602718.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Veracyte, Inc. | 45.81 |
| bioAffinity Technologies, Inc. | 6.055 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Agenus, Inc. | 8.36 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
Price Related Metrics
| PS Ratio | 41.72 |
| Price to Book Value | 3.655 |
| Earnings Yield | -281.1% |
| Market Cap | 33.16M |